GSK Aktie
18,14
EUR
-0,09
EUR
-0,49
%
15,09
GBP
-0,02
GBP
-0,13
%
Werbung
GSK Aktie Analyse
20.02.25 | GSK Outperform | Bernstein Research | |
17.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
10.02.25 | GSK Hold | Deutsche Bank AG | |
07.02.25 | GSK Outperform | Bernstein Research | |
07.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
07.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
06.02.25 | GSK Hold | Deutsche Bank AG | |
06.02.25 | GSK Neutral | UBS AG | |
Werbung
|
|||
05.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
05.02.25 | GSK Outperform | Bernstein Research | |
05.02.25 | GSK Neutral | UBS AG | |
05.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
30.01.25 | GSK Neutral | UBS AG | |
20.01.25 | GSK Hold | Jefferies & Company Inc. | |
15.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
10.01.25 | GSK Hold | Deutsche Bank AG | |
07.01.25 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.01.25 | GSK Outperform | Bernstein Research | |
18.12.24 | GSK Hold | Deutsche Bank AG | |
18.12.24 | GSK Neutral | Goldman Sachs Group Inc. | |
17.12.24 | GSK Hold | Deutsche Bank AG | |
11.12.24 | GSK Neutral | Goldman Sachs Group Inc. | |
11.12.24 | GSK Underweight | JP Morgan Chase & Co. | |
10.12.24 | GSK Hold | Jefferies & Company Inc. | |
06.12.24 | GSK Hold | Deutsche Bank AG | |
05.12.24 | GSK Neutral | Goldman Sachs Group Inc. | |
03.12.24 | GSK Underweight | JP Morgan Chase & Co. | |
02.12.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
25.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
15.11.24 | GSK Hold | Deutsche Bank AG | |
14.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
12.11.24 | GSK Hold | Jefferies & Company Inc. | |
01.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
31.10.24 | GSK Buy | Deutsche Bank AG | |
31.10.24 | GSK Neutral | UBS AG | |
31.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
30.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
30.10.24 | GSK Neutral | UBS AG | |
30.10.24 | GSK Outperform | Bernstein Research | |
30.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
25.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
21.10.24 | GSK Neutral | UBS AG | |
11.10.24 | GSK Buy | Deutsche Bank AG | |
11.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
10.10.24 | GSK Buy | Deutsche Bank AG | |
10.10.24 | GSK Neutral | UBS AG | |
10.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
09.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
09.10.24 | GSK Buy | Deutsche Bank AG |
Werbung
Werbung